Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tilray Brands Inc (TLRY) vs Zscaler Inc (ZS) Price & Performance

Tilray Brands IncTrade
Zscaler IncTrade

Price performance (Past 24H)

Key statistics

Tilray Brands Inc vs Zscaler Inc — how do they compare? Tilray Brands Inc trades at $3.54 (market cap $530.54M), while Zscaler Inc trades at $233.73 (market cap $35.35B). The key difference: Zscaler Inc is far larger — about 66.6× Tilray Brands Inc's market cap, and Zscaler Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and Zscaler Inc for 41 Days on average.

TLRYZS
Market Cap
$530.54M$35.35B
Volume
9,099,0753,726,203
Sector
HealthTechnology
52-Week High
$17.20$336.27
52-Week Low
$3.54$118.05
Typical Hold Time
31 Days41 Days
Enterprise Value
$684.46M$33.73B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tilray Brands Inc

Tilray Brands (TLRY) trades at $3.59, down 3.36% on the day and near 52-week lows, with bearish technical indicators dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings have consistently missed expectations, though analyst consensus remains cautiously optimistic with a $65.01 price target. The stock faces significant headwinds from ongoing profitability challenges and cannabis industry volatility.

TLRY presents a high-risk opportunity with potential upside if management can achieve profitability and capitalize on cannabis reform catalysts. However, persistent losses, negative cash flow, and competitive pressures create substantial downside risk. Investors should weigh the speculative nature against potential regulatory catalysts in the coming months.

Zscaler Inc

Zscaler (ZS) trades at $216.99, up 1.61% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $1.1B in 2022 to $2.67B in 2025, though remains unprofitable with a -1.88% net margin. Recent quarters have consistently beaten EPS estimates, while analyst sentiment remains overwhelmingly positive with 79.63% buy ratings and a $222.83 consensus target.

ZS presents growth potential through cybersecurity demand and AI product expansion, but faces execution risks from leadership changes and competitive pressures. The stock trades at premium valuations (P/S 10.36) while still losing money, creating both opportunity and vulnerability if growth slows or margins don't improve as expected.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TLRY
54% Buy46% Sell
Avg holding period · 31 Days
ZS
52% Buy48% Sell
Avg holding period · 41 Days

Top news

Latest headlines on both assets

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →

About Zscaler Inc

Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.

Read more on ZS →